Predicting Low Accrual in the National Cancer Institute’s Cooperative Group Clinical Trials

Clinical trials in crisis: Four simple methodologic fixes

(2014) Andrew J Vickers   Clinical Trials

Characteristics of Oncology Clinical Trials

(2013) Bradford R. Hirsch et al.   JAMA Internal Medicine

The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical Center

(2011) Darlene R. Kitterman et al.   ACADEMIC MEDICINE

The Importance of Doing Trials Right While Doing the Right Trials

(2011) D. M. Dilts et al.   CLINICAL CANCER RESEARCH

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

(2011) A. T. Schroen et al.   CLINICAL CANCER RESEARCH

Predicting Accrual Achievement: Monitoring Accrual Milestones of NCI-CTEP-Sponsored Clinical Trials

(2011) S. K. Cheng et al.   CLINICAL CANCER RESEARCH

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

(2011) Anneke T Schroen et al.   Clinical Trials

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

(2010) Anneke T Schroen et al.   Clinical Trials

Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007

(2010) Edward L. Korn et al.   JOURNAL OF CLINICAL ONCOLOGY

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer

(2010) Olivier Graesslin et al.   JOURNAL OF CLINICAL ONCOLOGY

Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ

(2010) Udo Rudloff et al.   JOURNAL OF CLINICAL ONCOLOGY

Methods for the thematic synthesis of qualitative research in systematic reviews

(2008) James Thomas et al.   BMC Medical Research Methodology